Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
3,206,188
-
Shares change
-
+724,310
-
Total reported value, excl. options
-
$20,847,000
-
Value change
-
+$4,718,786
-
Put/Call ratio
-
114%
-
Number of buys
-
33
-
Number of sells
-
9
-
Price
-
$6.50
Institutional Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q4 2017
As of 31 Dec 2017 Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) had 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,206,188 shares of stock of the company.
Largest 10 holders included Vanguard Group Inc, Skylands Capital, LLC, Manatuck Hill Partners, LLC, MILLENNIUM MANAGEMENT LLC, B. Riley Financial, Inc., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES & ASSOCIATES, PEAK6 Investments, L.P., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This table shows 57 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.